Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

Scaling Mental Health, But Not at All Costs

Going Digital: Behavioral Health Tech is the leading community and media business committed to expanding access to mental health and substance use services through technology and innovation. Our community is made up of health plans, employers, health systems, behavioral health providers, startups, investors and policymakers to connect for the purposes of advancing access to behavioral healthcare for all. We solve the inertia of access to quality behavioral healthcare by convening all stakeholders to develop, adopt and improve behavioral health tech and innovation.

The healthcare industry is grappling with how to address the dire mental health and substance use crisis. Funding has poured into behavioral health technology startups and innovations these last few years, but is it sustainable? Join us for a dedicated behavioral health program at HLTH with payors, providers, pharma, startups and investors to discuss how to scale behavioral health solutions. We will cover affordability, the provider crisis, how to decipher high-quality solutions through the noise, and measuring outcomes for patients.  Host: Solome Tibebu, Founder &amp; CEO, Going Digital 10:05am - 10:50am: How Health Plans Are Scaling Mental Health Innovation From The Outside InModerator: Shirley Bergin, former COO and Executive Director, TEDMED and current Chief Innovation Officer, Ellipsis HealthPanelists:Dr. Cara McNulty, DPA, President of Behavioral Health and Mental Wellbeing, CVS HealthEva Borden, President of Behavioral Health, EvernorthSuzanne Kunis, Vice President of Behavioral Health, Horizon Blue Cross Blue Shield of New Jersey 10:55am - 11:40am: What Role Does Pharma Have in Scaling Mental Health SafelyModerator: Dr. Murray Zucker, Medical Director, TwillPanelists: Dr. Satish Singh, Associate Director of Strategic Partnerships, BiogenJeff Weness, Head of Digital Opportunities and Investments, OtsukaSaad Shah, Head of Digital Health Technology Strategy &amp; Innovation Business Development Team, Amgen 11:45am - 12:25pm: The Venture Capitalists&#39; Perspective on Scaling Mental HealthModerator: Margaret Laws, Founder and CEO, HopelabPanelists:Laura Veroneau, Partner, Optum VenturesLiam Donohue, Partner, .406 VenturesObadiah Sang, Managing Director, Head of Corporate Development &amp; Strategic Investing, Independence Blue Cross 12:25pm - 1:00pm: Networking

Partner Programs

Global Health Connector Partnership Summit

The European Connected Health Alliance Group (ECHAlliance Group) is the Global Health Connector for Digital Health, facilitating multi-stakeholder connections around ecosystems, driving sustainable change and disruption in the delivery of health and social care.

The Global Health Connector Partnership (GHCP) will meet once again during HLTH, the preeminent event in the healthcare industry in Las Vegas. The attendees of the GHCP Summit will enjoy a pleasant and productive breakfast session, where they will have the opportunity to hear from our international speakers discussing Disparities Globally, Digital Skills Workforce and Data and Digital Services. The breakfast will bring our attendees an incredible opportunity to network with key global industry stakeholders across the health ecosystem across the private and public sectors. 7:30am – 8:00am: Networking &amp; Breakfast 8:00am – 8:05am: Introduction &amp; WelcomeSpeaker: Brian O’Connor, Chair of ECHAlliance 8:05am – 8:25am: Green HealthSpeakers:Julien Venne, Director Digital Health SocietyKen Somers, Partner &amp; Master Expert at McKinsey &amp; Company 8:25am – 8:45am Disparities GloballyModerator: Andy Bleaden, Community Director ECHAllianceSpeakers:Ann Mond Johnson, CEO at American Telemedicine AssociationMohamed El Sahili, CEO/CVO Medland Hospital 8:50am – 9:10am: Digital Skills WorkforceSpeakers:George Crooks, Chief Executive Officer Digital Health &amp; Care InstituteJon Warner, US President- ORCHA Health 9:10am – 9:30am: Data and Digital ServicesSpeakers:Bleddyn Rees, Chair at The Digital Health SocietyKari Kohtamäki, Senior Advisor at VTT 9:30am – 9:40am: Closing &amp; RemarksSpeakers:Brian O’Connor, Global Health Connector PartnershipRich Scarfo, President at HLTH

Digital Therapeutics: An Industry is Growing up & Breaking Out!

Evercore ISI and Digital Therapeutics Alliance are pleased to host a variety of sessions to discuss key topics relevant to the ever-changing DTx Landscape inclusive of providers, payors, and pharma companies, both domestically and overseas. Our high-profile speakers are here to share their insights and advice as it relates to regulation and reimbursement, commercialization, and value-add partnerships

Evercore ISI serves more than 1,300 institutional investors globally, representing the largest asset managers and fund complexes in the world. At Evercore ISI, our experienced Research, Sales and Trading professionals deliver superior client service on a content-led platform. Every day, we strive to be The Street’s best investment research resource to support our clients’ overall money management needs.

Moving the Needle on Commercial Reimbursement

One of the key ongoing challenges that DTx faces is attaining coverage from payors; during our first session, we hope to shed light on what payors are looking for clinically and economically (hint: it&#39;s evidence). Moderator: <a href="https://www.linkedin.com/in/jessica-hauflaire-51063b33/" target="_blank" style="color: rgb(6, 23, 234);">Jessica Hauflaire</a>, COO, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/julia-m-strandberg/" target="_blank" style="color: rgb(6, 33, 231);">Julia Strandberg</a>, Chief Commercial Officer, Pear Therapeutics<a href="https://www.linkedin.com/in/josephperekupka/" target="_blank" style="color: rgb(6, 33, 231);">Joe Perekupka</a>, CEO, Freespira <a href="https://www.linkedin.com/in/jason-parent-msn-aprn-fnp-c-3978a71a" target="_blank" style="color: rgb(6, 33, 231);">Jason Parent</a>, Director, Clinical Innovation, Point32Health

DTx in Capitol Hill

In September, our esteemed colleagues at DTA held a Capitol Hill Advocacy Event to promote awareness and discuss policies and legislation that provide better access and coverage to DTx. Today, they share what they took away from those meetings and discuss the relevance of the Access to Prescription Digital Therapeutics Act of 2022. Moderator: <a href="https://www.linkedin.com/in/andy-molnar/" target="_blank" style="color: rgb(6, 23, 234);">Andy Molnar</a>, CEO, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/liesloldstone/" target="_blank" style="color: rgb(6, 23, 234);">Liesl Oldstone</a>, VP, Health Economics and Market Access, AppliedVR<a href="https://www.linkedin.com/in/everett-crosland-018aba13/" target="_blank" style="color: rgb(6, 23, 234);">Everett Crosland,</a> Chief Commercial Officer, Cognito Therapeutics

DTx: International Landscape

While the US is an early adopter of DTx, we can learn much from earlier pioneers and their success stories overseas. Our panelists hope to share their insights as to what is and isn&#39;t working internationally. Moderator: <a href="https://www.linkedin.com/in/megan-coder-a10444b/" target="_blank" style="color: rgb(6, 23, 234);">Megan Coder</a>, Chief Policy Officer, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/hanneskloepper/" target="_blank" style="color: rgb(6, 23, 234);">Hannes Klopper,</a> CEO, HelloBetter <a href="https://www.linkedin.com/in/jydkim/" target="_blank" style="color: rgb(6, 23, 234);">Danny Kim</a>, Head of WELT USA, WELT

Making Your DTx Product Launch a Success the First Time

With the industry still in its early stages, there hasn&#39;t been a playbook for success...until now! With DTA&#39;s recently developed Product Launch Playbook, we bring together key experts who have and continue to navigate their way through their respective product launches. Moderator: <a href="https://www.linkedin.com/in/lani-hessen-otr-l-462a881/" target="_blank" style="color: rgb(6, 23, 234);">Lani Hessen</a>, VP, Patient Access, Digital Therapeutics AlliancePanelists:<a href="https://www.linkedin.com/in/jennifer-lavanture-18110a21/" target="_blank" style="color: rgb(6, 23, 234);">Jennifer Lavanture</a>, VP of Business Development, MedRhythms<a href="https://www.linkedin.com/in/sarahtraffordkoenig/" target="_blank" style="color: rgb(6, 23, 234);">Sarah Koenig</a>, Senior Director and Head of Marketing, Freespira<a href="https://www.linkedin.com/in/vjbala" target="_blank" style="color: rgb(6, 23, 231);">VJ Bala</a>, Senior Vice President, Marketing, Propeller Health<a href="https://www.linkedin.com/in/katelynkreitzer/" target="_blank" style="color: rgb(6, 23, 234);">Katie Kreitzer,</a> Lead Content Designer, Limbix

Partnering with Pharma: What Works?

Pharmaceutical partnerships offering a variety of benefits including access to far greater resources, expertise, and commercial relationships. Listen in on what works when pursuing a partnership with pharmaceutical companies. Moderator: Elizabeth Anderson, Managing Director, Evercore ISISpeakers:Jorge Cancela, Digital Health Leader, RocheOfer Leidner, Co-Founder and President, TwillJason Hawbecker, Head of Strategic Partnerships, Biogen